Acute leukemia in infants. A unique pattern of acute nonlymphocytic leukemia

The American Journal of Pediatric Hematology/oncology
E R van Wering, W A Kamps

Abstract

At present, the majority of children with acute lymphoblastic leukemia can expect a favorable outcome. However, leukemia in infants (0-1 year) still runs a dismal course. The first year of life also has a unique pattern of hematopoietic activity. We investigated possible association between these two findings. We examined the characteristics of 51 infants with leukemia, diagnosed from 1975 to 1984; 48/51 had evaluable data. Infants had a high frequency (39.6%) of hyperleukocytosis (greater than 100 X 10(9)/liter), early central nervous system involvement (27.1%), and cutaneous infiltration (18.8%). The respective numbers in patients greater than or equal to 1 year were 13.9, 4.8, and 1.0%. Acute nonlymphocytic leukemia was diagnosed in 18/48 infants (37.5%) compared to 128/892 (14.3%) in older patients. Infants had only acute leukemia of French-American-British (FAB) class M5 (10/19) or acute leukemia with unclassifiable but monocytoid blasts (8/19). This study confirms the presence of poor prognostic features in infant leukemia. The almost exclusive occurrence of monoblastic or monocytoid acute leukemia parallels the high proliferation rate of monocytes in this age group and the leukemic cells may thus well reflect frozen stag...Continue Reading

Citations

Nov 28, 1987·Lancet·D Pinkel
Jan 1, 1993·Cancer Investigation·F Boulad, N A Kernan
Feb 19, 2008·Current Problems in Pediatric and Adolescent Health Care·Patrick A Zweidler-McKay, Joanne M Hilden
Mar 24, 2005·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·M E Rendón-MacíasA Fajardo-Gutiérrez
Mar 11, 2010·Pediatric Emergency Care·Waleed AlqurashiDavid McGillivray
Mar 22, 2006·Pediatric Blood & Cancer·Ryoji KobayashiUNKNOWN Japanese childhood AML cooperative study group
Dec 12, 2001·Journal of Pediatric Gastroenterology and Nutrition·T H JaingC C Luo
Mar 1, 2000·Journal of Pediatric Hematology/oncology·R D JenkinR Sabbah
Aug 4, 2009·The Laryngoscope·Stephen F ConleyShun-Hwa Li
Apr 17, 1999·Journal of Pediatric Hematology/oncology·M C FernandezK K Matthay
Sep 4, 1999·Seminars in Perinatology·J E SandeB C Lampkin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.